Ginkgo Bioworks' Shetty proposes $227K share sale
The notice ties the shares to restricted stock vesting and says the sale includes shares needed to cover a related tax obligation.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Ginkgo Bioworks Holdings, Inc. (DNA) is the issuer in a notice listing officer and director Reshma Shetty’s proposed sale of 22,369 Class A shares, with an aggregate market value of $226,879.82. The notice lists October 19, 2026, as the approximate sale date and Fidelity Brokerage Services LLC as broker, with NYSE named as the exchange. The shares were acquired through restricted stock vesting on October 16, 2026; the sale includes an amount necessary to cover a tax obligation resulting from settlement of a vested equity award distribution.
Key Figures
Key Terms
Rule 144 regulatory
Restricted Stock Vesting financial
vested equity award distribution financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.